Sensei Biotherapeutics Inc reports results for the quarter ended in June - Earnings Summary

Faeth Therapeutics,

09/08/2022 14:50

* Sensei Biotherapeutics Inc  SNSE.OQ  reported a quarterly
adjusted loss of 34 cents​​ per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of 39 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Sensei Biotherapeutics Inc's reported EPS for the quarter
was a
loss of 34 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Sensei Biotherapeutics Inc shares had fallen by 9.7% this
quarter and lost 64.7% so far this year.
    * The company reported a quarterly loss of $10.54 million.
    * Wall Street's median 12-month price target for Sensei
Biotherapeutics Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 01:50 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.39          -0.34          Beat
 Mar. 31 2022      -0.35          -0.40          Missed
 Dec. 31 2021      -0.34          -0.30          Beat
 Sep. 30 2021      -0.24          -0.32          Missed